Results 131 to 140 of about 2,338,562 (193)

Nursing consultation based on supported self-care for the management of type 2 diabetes mellitus: a quasi-experimental study. [PDF]

Rev Lat Am Enfermagem
Teston EF, Brito GS, Palasson RR, Dias TG, Arruda GO, Marcon SS.   +5 more
europepmc   +1 more source

[Metabolic Dysfunction-Associated Steatotic Liver Disease and its association with prediabetes in adolescents with obesity]. [PDF]

Rev Med Inst Mex Seguro Soc
Peralta-Cortázar C, García-Gómez DB, González AP, Guardado-Mendoza R, Gómez-Nájera M, Paque-Bautista C, Hernández-Solorio MÁ, Cortés-Salim P, Sosa-Bustamante GP.   +8 more
europepmc   +1 more source

Alteraciones de colesterol total triglic\ue9ridos colesterol-HDL colesterol-LDL h\ue1bitos enfermedades concominantes y tratamiento recibido en los pacientes que asisten a la consulta de medicina interna del Ambulatorio Urbano Tipo III "Dr Daniel Camejo Ac

La presente investigaci\uf3n, tuvo corno objetivo principal determinar las alteraciones de triglic\ue9ridos, colesterol total, colesterol-HDL, colesterol-LDL, h\ue1bitos, enfermedades concomitantes y tratamiento recibido en los pacientes que asisten a la
P\ue1ez V., Jenny
core  

Brazilian Guideline on Dyslipidemias and Prevention of Atherosclerosis - 2025. [PDF]

Arq Bras Cardiol
Rached FH, Miname MH, Rocha VZ, Zimerman A, Cesena FHY, Sposito AC, Santos RDD, Behr PEB, Bianco HT, Alves RJ, Faludi AA, Coutinho EDR, Fonseca FAH, Carvalho LSF, Bertolami A, Rocha AMD, Marte AP, Chagas ACP, Caramelli B, Polanczyk CA, Ferreira CEDS, Serrano Junior CV, Araujo DB, Moriguchi EH, Pinto FJ, Moreira HG, Back IC, Faria Neto JR, Maia KAP, Bertolami MC, Assad MHV, Izar MCO, Barreto MA, Barreto NSF, Silva PGMBE, Pimentel Filho P, Maranhão RC, Kaiser SE, Machado VA, Saraiva JFK.   +39 more
europepmc   +1 more source

Más allá del colesterol LDL: valor del colesterol no-HDL como predictor de eventos cardiovasculares ateroscleróticos en pacientes con infarto con elevación del segmento ST

Background: In cardiovascular disease (CVD), lowering low-density lipoprotein cholesterol (LDL-C) remains the primary the-rapeutic goal to reduce major adverse cardiovascular events (MACE).
Pacce, Ornella, Perea, Joaquín, Villarreal, Ricardo, Vargas Parraga, Elena, Sosa Liprandi, Alvaro, Janches Quiñones, Julia, Fiori, Anabella E., Cardozo, Daniela   +7 more
core  

The "No-Reflow" Phenomenon Far Beyond the Cath Lab. [PDF]

Arq Bras Cardiol
Pozetti AH, Ribeiro HB.
europepmc   +1 more source

[PlanHaSSO: Healthy Habits Plan against Overweight and Obesity. Research project for the development of a protocolized program for primary care]. [PDF]

Aten Primaria
Aznar Salas R, Navarro López J, Moreno Loscertales C, Longás Valién J, Martínez Peralta B, Aznar Salas T.   +5 more
europepmc   +1 more source

From Cholesterol Metabolism to Comprehensive Lipid Management and Crosstalk of Inflammation: Expanding the Frontiers of Cardiovascular Prevention. [PDF]

Arq Bras Cardiol
Vilela E, Bettencourt N.
europepmc   +1 more source

Fine Particulate Pollution is a Powerful Risk Factor for Cardiovascular Disease. [PDF]

Arq Bras Cardiol
Favarato D.
europepmc   +1 more source

[Genetic Susceptibility to Metabolic Syndrome: A Comparative Overview of the Mexican Population in a Global Context]. [PDF]

Rev Med Inst Mex Seguro Soc
Gallardo-Hernández CA, Díaz-Alberto J, Palma-Jacinto JA, Montero-Ruíz O, Ramírez-Franco U.   +4 more
europepmc   +1 more source